Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,065 across all filing types
Latest filing 2021-12-21 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
DISCLOSEABLE AND CONNECTED TRANSACTIONS - TRANSACTION ARRANGEMENTS: DELAY IN COMPLETION OF WTGL SP AGREEMENT
Capital/Financing Update Classification · 95% confidence The document is an announcement related to a delay in the completion of a specific transaction agreement (WTGL SP Agreement) involving share sale and purchase. It references previous announcements and circulars but primarily focuses on updating shareholders and the market about the extension of the completion date and the status of the transaction. There are no financial statements or detailed financial data presented, nor is this a full report or earnings release. The document is a regulatory announcement about a transaction update, not a full M&A filing or merger proxy statement. Given the nature of the content—an update on transaction arrangements and delay in completion—it fits best under Capital/Financing Update (CAP). The document length is short (4051 characters), and it is not merely announcing the publication of a report but providing substantive update information. Therefore, the classification is CAP with high confidence.
2021-12-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 November 2021. It details movements in authorized and issued share capital, share options, and confirmations related to securities issued by the issuer. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and share option movements for a specific month. It does not contain financial statements, earnings data, or management discussion. It is a regulatory filing reporting share capital movements and confirmations, fitting the category of Regulatory Filings (RNS).
2021-12-03 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Uni-Bio Science Group Limited. It details repurchases of shares, cancellations, and the resulting changes in issued share capital. The document references compliance with listing rules of the Stock Exchange of Hong Kong and provides detailed data on share repurchases and cancellations. This type of document is a regulatory disclosure about transactions in the company's own shares, specifically share buybacks and cancellations. It is not an annual report, earnings release, or management discussion. It is not a proxy statement or voting result. It is a formal disclosure of share repurchase activity. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support a high confidence in this classification.
2021-12-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return on movements in securities, specifically focusing on share capital, issued shares, share options, and confirmations related to securities issued by Uni-Bio Science Group Limited. It includes detailed tables on authorized and issued shares, share options under the share option scheme, and confirmations by the company secretary regarding compliance with listing rules. The document is addressed to the Hong Kong Exchanges and Clearing Limited and is a regulatory submission related to share capital movements and securities issuance for the month ended 31 October 2021. It does not contain financial statements, earnings data, or management discussion, nor is it an announcement of a report publication. It is a regulatory filing providing detailed compliance and share capital information as required by the exchange rules. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-11-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 September 2021. It details movements in authorized and issued share capital, share options, and confirmations related to securities issued during the month. The content focuses on share capital changes and confirmations required by the Hong Kong Stock Exchange listing rules. It is a regulatory submission reporting share capital movements and share option details, not a financial report, earnings release, or management discussion. The document is a regulatory filing related to compliance with listing rules and securities movements, fitting the category of Regulatory Filings (RNS).
2021-10-04 English
NOTIFICATION LETTER AND REQUEST FORM
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 13 September 2021 from Uni-Bio Science Group Limited informing shareholders that the 2021 interim report for the six months ended 30 June 2021 has been published on the company's website. It includes instructions on how shareholders can request a printed copy of the interim report and other corporate communications. The document does not contain the interim report itself or any financial data, but rather serves as a notice of publication and availability of the report. The document length is 4667 characters, which is relatively short and consistent with a notification rather than a full report. Therefore, according to the 'Menu vs Meal' rule, this document should be classified as a Report Publication Announcement (RPA).
2021-09-10 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.